Revvity (RVTY) Proxy Filing summary
Event summary combining transcript, slides, and related documents.
Proxy Filing summary
6 Mar, 2026Executive summary
The annual meeting will be held virtually on April 28, 2026, with shareholders able to vote electronically or by proxy as of the March 2, 2026 record date.
Key agenda items include director elections, auditor ratification, executive compensation, by-law amendment for special meetings, and a shareholder proposal on executive stock retention.
The board recommends voting for all management proposals and against the shareholder proposal.
Voting matters and shareholder proposals
Election of ten directors for one-year terms.
Ratification of Deloitte & Touche LLP as independent auditor for fiscal 2026.
Non-binding advisory vote on executive compensation (say-on-pay).
Amendment to by-laws to allow shareholders with 25% ownership to call a special meeting.
Shareholder proposal requiring executives to retain significant stock, which the board opposes.
Board of directors and corporate governance
Board consists of ten members, nine of whom are independent; leadership is split between a Non-Executive Chair and CEO.
Annual board self-evaluation and review of independence.
Committees include audit, nominating and corporate governance, and compensation and benefits, all with independent members.
Shareholders can recommend or directly nominate director candidates.
Proxy access allows groups owning 3%+ for three years to nominate directors.
Latest events from Revvity
- Key votes include director elections, auditor ratification, and by-law amendment for special meetings.RVTY
Proxy Filing16 Mar 2026 - Board recommends all management proposals, including by-law amendment, and opposes stock retention proposal.RVTY
Proxy Filing16 Mar 2026 - AI-powered Signals launches and new revenue models drive growth amid cautious market outlook.RVTY
Barclays 28th Annual Global Healthcare Conference10 Mar 2026 - Cost actions and innovation drive margin expansion and growth across diagnostics and software.RVTY
TD Cowen 46th Annual Health Care Conference3 Mar 2026 - Innovation and operational excellence drive growth, with AI and margin expansion as key themes.RVTY
47th Annual Raymond James Institutional Investor Conference2 Mar 2026 - Q2 revenue fell 2% but adjusted EPS rose and buybacks will accelerate.RVTY
Q2 20242 Feb 2026 - 2025 revenue and EPS rose; 2026 targets further growth, margin gains, and innovation.RVTY
Q4 20252 Feb 2026 - Portfolio transformation and recurring revenue drive margin expansion and growth opportunities.RVTY
Goldman Sachs 45th Annual Global Healthcare Conference1 Feb 2026 - Differentiated portfolio and strong execution fuel above-peer growth and robust cash flow.RVTY
2024 Wells Fargo Healthcare Conference22 Jan 2026